Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Recursion Pharmaceuticals
AddedFeb 19, 2024
UpdatedJun 24, 2026
Recursion Pharmaceuticals

Recursion Pharmaceuticals

Public

Recursion Pharmaceuticals: An American company innovating hereditary disease treatments.

HQ
Salt Lake City, UT, US
Founded
2013
Overview
Compare
Fundraising
Employees
Website

Recursion Pharmaceuticals is an American company dedicated to researching, discovering, and developing pharmaceuticals. The company focuses on understanding the interaction of known bioactive compounds with hereditary diseases, aiming to innovate treatments that address these genetic conditions.

Recursion Pharmaceuticals has made significant strides in the pharmaceutical industry, leveraging advanced technologies to accelerate drug discovery and development. Their impactful work has garnered attention and support from notable investors, contributing to advancements in hereditary disease treatments.

Recursion Pharmaceuticals - Products & Services

  • Recursion OS logo

    Recursion OS

    Recursion OS is an AI-powered drug discovery and development platform built on massive proprietary biological and chemical datasets.

    Competing Products

    Lila Sciences logo
    Lila Sciences logo
    Genesis Therapeutics logo
    Origin Bio logo

Recursion Pharmaceuticals - Similar Companies

Isomorphic Labs logo

Isomorphic Labs

Lila Sciences logo

Lila Sciences

lila.ai

Genesis Therapeutics logo

Genesis Therapeutics

Regeneron Ph logo

Regeneron Ph

regeneron.com

Insilico Medicine logo

Insilico Medicine

insilico.com

Insitro logo

Insitro

insitro.com

BridgeBio Pharma logo

BridgeBio Pharma

bridgebio.com

ReCode Therapeutics logo

ReCode Therapeutics

Recida Therapeutics logo

Recida Therapeutics

Reset Pharmaceuticals logo

Reset Pharmaceuticals

Kyntra Bio logo

Kyntra Bio

fibrogen.com

Regenerative Bio logo

Regenerative Bio

regen-bio.us

Orig3N logo

Orig3N

orig3n.com

Sequence Bio logo

Sequence Bio

sequencebio.com

BridGene Biosciences logo

BridGene Biosciences

Recursion Pharmaceuticals - Quick Facts

Who are Recursion Pharmaceuticals' competitors?

Companies similar to Recursion Pharmaceuticals include Lila Sciences, Genesis Therapeutics, Isomorphic Labs and Regeneron Ph.

When was Recursion Pharmaceuticals founded?

Recursion Pharmaceuticals was founded in 2013.

Where is Recursion Pharmaceuticals' headquarters located?

Recursion Pharmaceuticals' headquarters is located in Salt Lake City, UT, US.

When was Recursion Pharmaceuticals' last funding round?

Recursion Pharmaceuticals' most recent funding round was for $50M (USD) in July 2023.

How much has Recursion Pharmaceuticals raised to-date?

As of Jul 12, 2023, Recursion Pharmaceuticals has raised a total of $665.4M (USD).

How many employees does Recursion Pharmaceuticals have?

Recursion Pharmaceuticals has 500 employees as of Feb 6, 2024.

Recursion Pharmaceuticals - Classification

Ownership
  • Public
  • Venture Capital
Technology
  • AI
  • Machine Learning
Geographic Exposure
  • Global
Model
  • Platform
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Tags
  • AI Operations
  • Biotech
  • Healthcare
Unique IDs
  • ein: 464099738
  • secCik: 0001601830
  • ticker: RXRX
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 2836Biological Products, Except Diagnostic Substances
  • 2800Chemicals And Allied Products
  • 2830Drugs
ISIC
  • 2100Manufacture of pharmaceuticals, medicinal chemical and botanical products
Show 16 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325414Biological Product (except Diagnostic) Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 4000Railroad Transportation
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research